Skip to Main Content

Author Details

Elizabeth J Perlman
Ann & Robert H. Lurie Children's Hospital of Chicago
1989
241
67
PMIDPaper TitleJournal TitlePublished Year
37933882Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.Cancer2024
37848532Hallmark discoveries in the biology of Wilms tumour.Nat Rev Urol2024
37933882Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.Cancer2024
37902955Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.Cancer2024
37902955Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.Cancer2024
37848532Hallmark discoveries in the biology of Wilms tumour.Nat Rev Urol2024
37343199Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.J Clin Oncol2023
37584517Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors.Cancer Res2023
37343199Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.J Clin Oncol2023
37584517Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors.Cancer Res2023
35076770ASO Video Abstract: Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis-A Report from the Children's Oncology Group Study AREN0534.Ann Surg Oncol2022
35383900Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).Cancer2022
35617957Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.Cell Rep Med2022
35276672Authors' Reply to the Letter to the Editor by Daniel M. Green.J Natl Compr Canc Netw2022
35275409Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences.Histopathology2022
35076770ASO Video Abstract: Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis-A Report from the Children's Oncology Group Study AREN0534.Ann Surg Oncol2022
35072864Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534.Ann Surg Oncol2022
35617957Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.Cell Rep Med2022
35383900Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).Cancer2022
35072864Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534.Ann Surg Oncol2022
35276672Authors' Reply to the Letter to the Editor by Daniel M. Green.J Natl Compr Canc Netw2022
35275409Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences.Histopathology2022
34261517Haplotype-resolved germline and somatic alterations in renal medullary carcinomas.Genome Med2021
34261517Haplotype-resolved germline and somatic alterations in renal medullary carcinomas.Genome Med2021
34416705Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.J Natl Compr Canc Netw2021
34416705Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.J Natl Compr Canc Netw2021
32160052Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.AJR Am J Roentgenol2020
32267967Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2.Cancer2020
32134700Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.J Clin Oncol2020
32160052Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.AJR Am J Roentgenol2020
32459384Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.Cancer2020
32926409A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.Cancer2020
32918070Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors.Nat Genet2020
32568472A child with neuroblastoma and metachronous anaplastic sarcoma of the kidney: Underlying DICER1 syndrome?Pediatr Blood Cancer2020
32918070Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors.Nat Genet2020
32926409A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.Cancer2020
32267967Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2.Cancer2020
32134700Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.J Clin Oncol2020
32459384Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.Cancer2020
32568472A child with neuroblastoma and metachronous anaplastic sarcoma of the kidney: Underlying DICER1 syndrome?Pediatr Blood Cancer2020
31391345Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.JCI Insight2019
31708418Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration.Cell Rep2019
30255545Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5).Pediatr Blood Cancer2019
31449468Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.J Clin Oncol2019
31325873Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.Eur J Cancer2019
31391345Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.JCI Insight2019
31708418Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration.Cell Rep2019
30255545Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5).Pediatr Blood Cancer2019
31325873Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.Eur J Cancer2019
31449468Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.J Clin Oncol2019
  • 1 - 50 of 482

Recommended Authors

Bhuvana A Setty
Ohio State University College of Medicine/Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 0
Malak Abedalthagafi
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 6
Alexandra E Kovach
Children's Hospital of Los Angeles
Career Start Year 2008
Number of shared co-authors 1
Zhongxin Yu
University of Oklahoma Health Sciences Center
Career Start Year 2005
Number of shared co-authors 7
Angshumoy Roy
Texas Children's Hospital and Baylor College of Medicine
Career Start Year 2004
Number of shared co-authors 2
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 12
Noah Federman
University of California los angeles
Career Start Year 2001
Number of shared co-authors 5
Franck Bourdeaut
SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris
Career Start Year 2001
Number of shared co-authors 17
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 26
Marilyn M Li
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 10
Scott C Borinstein
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 2
Brendan C Dickson
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 1997
Number of shared co-authors 9
Sara O Vargas
Boston Children's Hospital
Career Start Year 1997
Number of shared co-authors 6
Karoly Szuhai
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 5
Mariarita Santi
Children's Hospital of Philadelphia
Career Start Year 1997
Number of shared co-authors 18
Jaume Mora
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 22
Donald W Parsons
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 26
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 13
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 3
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 15
Michael Weintraub
Hadassah Hebrew University Hospital
Career Start Year 1992
Number of shared co-authors 4
Annie Huang
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Career Start Year 1990
Number of shared co-authors 16
Mary Shago
The Hospital for Sick Children, University of Toronto
Career Start Year 1990
Number of shared co-authors 11
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 14
Alberto S Pappo
St Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 36
Alexander O Vortmeyer
Indiana University School of Medicine
Career Start Year 1988
Number of shared co-authors 1
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 37
Jeremy A Squire
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 7
Daniel R Bou??
Nationwide Children's Hospital
Career Start Year 1982
Number of shared co-authors 7
David Malkin
Hospital for Sick Children
Career Start Year 1976
Number of shared co-authors 36

Collaborators

Elizabeth A Mullen
Co-authored papers 36
Robert C Shamberger
Boston Children's Hospital
Co-authored papers 28
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Co-authored papers 12
Pedram Argani
The Johns Hopkins Hospital
Co-authored papers 12
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 7
Murali Chintagumpala
Texas Children's Cancer Center, Baylor College of Medicine
Co-authored papers 7
Daniela S Gerhard
National Cancer Institute
Co-authored papers 7
Thomas M Link
Co-authored papers 7
Jaime M Guidry Auvil
National Cancer Institute
Co-authored papers 6
Malcolm A Smith
National Cancer Institute
Co-authored papers 6
Najat C Daw
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers 5
Andrew J Mungall
Co-authored papers 5
Peter C Burger
Co-authored papers 5
Richard A Moore
Co-authored papers 5
Marco A Marra
University of British Columbia
Co-authored papers 5
Yussanne Ma
Co-authored papers 5
Stanford T Shulman
Northwestern University Feinberg School of Medicine
Co-authored papers 5
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers 4
Ian C MacArthur
Co-authored papers 4
Anton G Henssen
Co-authored papers 4
Dana A Hill
Co-authored papers 4
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Co-authored papers 4
Hanno Steen
Boston Children's Hospital, USA Harvard Medical School, Harvard Medical School
Co-authored papers 4
Mark W Lingen
University of Chicago Pritzker School of Medicine
Co-authored papers 3
Montserrat Puiggròs
Co-authored papers 3
Stephen P Jackson
Mission Therapeutics Ltd. Glenn Berge Building
Co-authored papers 3
Anne-Katrin Emde
Variant Bio Inc.
Co-authored papers 3
Zhiping Weng
University of Massachusetts Medical School
Co-authored papers 3
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Co-authored papers 3
Release 1.2